Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section

A Phase 1, Multi-Center, Open-Label, dose Escalation Study of Thrombosomes in Bleeding thrombocytopenic Patients in Three Cohorts

Principal Investigator

Zbigniew Szczepiorkowski

Study Number

FED18023

Summary

This study evaluates in a dose-escalation manner, the safety, and preliminary impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in thrombocytopenic patients.

Phase

Phase I

Contact

Louise Marsh

Available at the following location(s)

  • Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms

0